"There's an R&D crisis" (in pharma)

Seen on ip-watch, a comment by Ellen ‘t Hoen of Médecins Sans Frontières: “I hope that the CIPIH report also gives clear guidance to both WHO and countries on how to tackle the health R&D crisis while ensuring that essential health products become affordable and available.”

This means there’s a crisis. Is IP the source of this crisis ? Can IP be used as a useful tool to get out of it ?